Respiratory and Critical Care Medicine Department

The Department of Respiratory and Critical Care Medicine at Peking University Shenzhen Hospital was established in 1999, initially named Respiratory Internal Medicine. It was approved as a master's degree granting discipline in 2003 and renamed Respiratory and Critical Care Medicine in 2019. In 2019, it was rated as an excellent unit for the creation of national respiratory and critical care medicine, and is one of the two excellent units in Shenzhen.

The Department of Respiratory and Critical Care Medicine currently has 2 wards with 58 fixed beds, including a respiratory outpatient comprehensive diagnosis and treatment center, a sleep respiratory disease diagnosis and treatment center, a respiratory endoscopy room, a pulmonary function room, a photodynamic darkroom, and 8 beds in the respiratory intensive care unit. The department has a complete range of sub specialty categories, including chronic airway diseases, sleep respiratory diseases, respiratory interventions, lung cancer, interstitial lung diseases, pulmonary vascular diseases, and other sub specialty directions.

The Department of Respiratory and Critical Care Medicine has an excellent medical, research, and teaching team. At present, there are a total of 40 medical staff, including 6 chief physicians/professors, 7 deputy chief physicians/associate professors, 3 attending physicians, and 2 resident physicians. Among them, 6 have obtained a medical doctorate degree, 3 have a master's degree, 1 is a postdoctoral fellow, and more than 20 nursing staff. We have advanced rescue and examination equipment both domestically and internationally, including invasive and non-invasive ventilators, various models of bronchoscopes for bronchial examination and treatment, ultrasound bronchoscopes, bronchoscope navigation systems, thoracoscopes, cryotherapy devices, laser knives, electric knives, nasal high flow oxygen therapy machines, defibrillators, etc.

The Department of Respiratory and Critical Care Medicine has gradually formed its disciplinary characteristics focusing on chronic airway diseases (asthma and chronic obstructive pulmonary diseases), interventional respiratory diseases (bronchoscopy and thoracoscopy), infectious diseases of the lung, lung cancer, etc. In terms of chronic airway diseases, a series of clinical and basic research has been carried out for the diagnosis and treatment of asthma and chronic obstructive pulmonary disease. It is a benchmark hospital for chronic disease management in China. In terms of interventional respiratory diseases, it has developed painless bronchoscopy and tracheal intubation general anesthesia techniques, ultrasound bronchoscopy examination, and lymph node biopsy (EBUS+TBNA). Through bronchoscopy intervention treatment techniques, including photodynamic therapy, high-frequency electrocautery, cryotherapy, laser, argon knife, balloon dilation, stent implantation, occluder placement, bronchial thermoforming, internal medicine lung volume reduction and other airway interventions, it alleviates benign and malignant airway stenosis caused by tumors, foreign bodies, infections, etc., carries out respiratory intervention treatment for chronic obstructive pulmonary asthma, and participates in the development of national level respiratory endoscopy expert consensus. The sentence is:; The internal medicine thoracoscopy diagnosis and treatment technology has been developed to help patients with pleural cavity diseases obtain correct diagnosis and treatment.

In the future, the department will continuously enhance its clinical and scientific research capabilities, focus on cultivating 2-3 advantageous discipline groups and cutting-edge technologies, and focus on developing the diagnosis and treatment technology and management of chronic respiratory diseases, comprehensive diagnosis and treatment of sleep respiratory diseases, and the construction of integrated diagnosis and treatment centers for pulmonary nodules and lung cancer. It will actively participate in the construction of major disease prevention and control systems at the provincial and municipal levels, and become a leading unit in this field in the region.